Three Commissioners for the Commission on Human MedicinesAnnounced
|Body:||Commission on Human Medicines|
|Appointing Department:||Department of Health|
|Number of Vacancies:||3|
|Remuneration:||Commissioners are currently remunerated at the standard rate of £325 per day.|
|Time Requirements:||Approximately 22 days per year, including 11 meetings.|
An announcement has been made on the outcome of this appointment.
Commission on Human Medicines (CHM) – Commissioners
Professor Jamie Coleman and Ms Susan Bradford have been appointed as Commissioners of the Commission for Human Medicines for 4 years from 1 September 2018.
The appointments will involve a time commitment of approximately 22 days per year, including 11 meetings. Remuneration for the roles will be at a standard rate of £325 for the preparation required and attendance at each Commission on Human Medicines meeting.
These appointments are made in accordance with the Cabinet Office Code of Governance for Public Appointments. The regulation of public appointments against the requirements of this Code is carried out by the Commissioner for Public Appointments.
The appointments are made on merit and political activity played no part in the decision process. However, in accordance with the Code, there is a requirement for appointees’ political activity (if any declared) to be made public. Professor Coleman and Ms Bradford have not declared any political activity.
Date: 06/07/2018View Announcement
Closed for Applications
Final Interview Date
06/07/2018 at 12:00
Professor Sir Michael Rawlins Added 29/01/2018
Chairman Medicines and Healthcare Products Regulatory Agency
Professor Stuart Ralston Added 29/01/2018
Chair of the Commission on Human Medicines
Dr Krishna Prasad Added 29/01/2018
Principal Assessor to the Commission on Human Medicines
Rima Makarem Added 29/01/2018
The Secretary of State for Health and Social Care is looking to appoint one lay and two specialist Commissioners to the Commission on Human Medicines (CHM). CHM is an Advisory Non-Departmental Public Body, set up in law to advise UK Health Ministers on the safety, quality and efficacy of medicines for human use and on the adverse drug reactions of marketed products.
As a Commissioner of the CHM you will be required to possess or develop a working knowledge and understanding of the UK/European medicines regulatory procedures. Commissioners consider, comment and contribute by drawing on their individual expertise and judgement, on all agenda items and assist the CHM to frame clear and unequivocal advice to Ministers.
We are looking for skilled communicators with the ability to operate effectively on a national expert scientific committee. The ability to assimilate complex scientific information at short notice and being prepared to contribute actively to the work of the CHM is essential.
The two specialist post applicants will need to be recognised by their peers and/or be Fellows of the relevant Royal Colleges and be either a Cardiologist or Pharmaco-toxicologist. An interest in pharmacogenomics/ pharmacogenetics would be an advantage.
Role and Responsibilities of the Commissioner
Commissioners are required to:
- possess or develop a working knowledge and understanding of the UK/European medicines regulatory procedures
- attend all scheduled and unscheduled meetings of the CHM (and to be present for the whole meeting)
- consider, comment and contribute by drawing on their individual expertise and judgement, as appropriate, on all agenda items and to assist the CHM to frame clear and unequivocal advice to Ministers in accordance with the CHM’s terms of reference
- be able and prepared to speak on a range of relevant issues and not just on their own areas of specialism
- provide formal and informal advice to Ministers between meetings when required
- provide advice relating to applications in the European Procedures and occasionally to attend the European Medicines Agency as part of the UK delegation as necessary
- contribute to and ensure the CHM’s advice takes account of a wider view of risk and benefit, particularly as it is perceived by patients, carers and other members of the public
Qualities required for the role of a Commissioner
To be considered, you must be able to demonstrate that you have the qualities, skills and experience to meet all the essential criteria for appointment.
- ability to operate effectively on a national expert scientific committee
- be skilled communicators
- ability to assimilate complex scientific information at short notice
- ability and prepared to contribute actively to the work of the CHM
In addition, for the two specialist posts successful candidates should also be:
- recognised by their peers and/or be Fellows of the relevant Royal Colleges
- be either a Cardiologist or Pharmaco-toxicologist. An interest in pharmacogenomics/pharmacogenetics would be an advantage
Background on some aspects of the CHM’s work
The secretariat to the CHM produces an Annual Report at the end of each calendar year which is laid before Parliament and made public.
A link to the 2016 report is available through the Gov.UK website: –
How to Apply
The Department of Health and Social Care Appointments and Honours Team is managing this recruitment campaign on behalf of Medicines and Healthcare Products Regulatory Agency (MHRA). To make an application please email your CV, a supporting letter and completed monitoring forms to:
firstname.lastname@example.org – please quote ref: A17-42 in the subject field.
If you are unable to apply by email you may send your application by post to:
Julia Peters, Department of Health and Social Care, Room 1N09, Quarry House, Quarry Hill, Leeds, LS2 7UE
Applications must be received by midday on 9nd March 2018.
The Department of Health and Social Care and MHRA promote diversity and encourage applications from all sections of the community.
|GUARANTEED INTERVIEW SCHEME|
|Information pack final closing 9.3.18|